Evidence map›Paper›PMID 33178223›Full record

ArticleFrontiers in immunology2020

CD28 Autonomous Signaling Orchestrates IL-22 Expression and IL-22-Regulated Epithelial Barrier Functions in Human T Lymphocytes.

Martina Kunkl, Carola Amormino, Simone Frascolla, Manolo Sambucci, Marco De Bardi, Silvana Caristi, Stefano Arcieri, Luca Battistini, Loretta Tuosto

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Martina KunklDepartment of Biology and Biotechnology Charles Darwin, Sapienza University, Rome, Italy.
Carola AmorminoDepartment of Biology and Biotechnology Charles Darwin, Sapienza University, Rome, Italy.
Simone FrascollaDepartment of Biology and Biotechnology Charles Darwin, Sapienza University, Rome, Italy.
Manolo SambucciNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Marco De BardiNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Silvana CaristiDepartment of Biology and Biotechnology Charles Darwin, Sapienza University, Rome, Italy.
Stefano ArcieriDepartment of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Luca BattistiniNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Loretta TuostoDepartment of Biology and Biotechnology Charles Darwin, Sapienza University, Rome, Italy.
Istituto Pasteur · ITFondazione Santa Lucia · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-22 is a member of the IL-10 cytokine family involved in host protection against extracellular pathogens, by promoting epithelial cell regeneration and barrier functions. Dysregulation of IL-22 production has also frequently been observed in acute respiratory distress syndrome (ARDS) and several chronic inflammatory and autoimmune diseases. We have previously described that human CD28, a crucial co-stimulatory receptor necessary for full T cell activation, is also able to act as a TCR independent signaling receptor and to induce the expression of IL-17A and inflammatory cytokines related to Th17 cells, which together with Th22 cells represent the main cellular source of IL-22. Here we characterized the role of CD28 autonomous signaling in regulating IL-22 expression in human CD4

Indexed as

Caco-2 CellsCD28 AntigensCD4-Positive T-LymphocytesHumansInterleukin-22InterleukinsMatrix Metalloproteinase 9Mucin-1Phosphatidylinositol 3-KinasesSignal TransductionCD28 AntigensInterleukin-22InterleukinsMatrix Metalloproteinase 9MMP9 protein, humanMUC1 protein, humanMucin-1Phosphatidylinositol 3-KinasesCD28epithelial cellIL-22inflammationT cell

Identifiers

PMID33178223
PMCPMC7592429
OpenAlexW3106218763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.